Xiamen Huanya Jiuzhou Trading Co., Ltd. – Trademark Portfolio

Entity Type: 99

Xiamen Huanya Jiuzhou Trading Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include OMIZONE. The owner is based in Xiamen.

Room 102-1, No. 189, Haitian Road, Huli District

Xiamen 361000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OMIZONE
OMIZONE
Registered 2025

Trademark Classifications

Xiamen Huanya Jiuzhou Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Xiamen Huanya Jiuzhou Trading Co., Ltd. have?

Xiamen Huanya Jiuzhou Trading Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Xiamen Huanya Jiuzhou Trading Co., Ltd. file in?

Xiamen Huanya Jiuzhou Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Xiamen Huanya Jiuzhou Trading Co., Ltd.'s most well-known trademarks?

Xiamen Huanya Jiuzhou Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as OMIZONE. These are among 1 currently registered trademark in the portfolio.

What is Xiamen Huanya Jiuzhou Trading Co., Ltd.'s trademark registration success rate?

Xiamen Huanya Jiuzhou Trading Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.